{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:30:27Z","timestamp":1792704627281,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T00:00:00Z","timestamp":1519948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T00:00:00Z","timestamp":1519948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tuberculosis remains a serious threat to human health world-wide, and improved efficiency of medical treatment requires a better understanding of the pathogenesis and the discovery of new drugs. In the present study, we performed a whole-cell based screen in order to complete the characterization of 168 compounds from the GlaxoSmithKline TB-set. We have established and utilized novel previously unexplored host-model systems to characterize the GSK compounds, i.e. the amoeboid organisms <jats:italic>D. discoideum<\/jats:italic> and <jats:italic>A. castellanii<\/jats:italic>, as well as a microglial phagocytic cell line, BV2. We infected these host cells with <jats:italic>Mycobacterium marinum<\/jats:italic> to monitor and characterize the anti-infective activity of the compounds with quantitative fluorescence measurements and high-content microscopy. In summary, 88.1% of the compounds were confirmed as antibiotics against <jats:italic>M<\/jats:italic>. <jats:italic>marinum<\/jats:italic>, 11.3% and 4.8% displayed strong anti-infective activity in, respectively, the mammalian and protozoan infection models. Additionally, in the two systems, 13\u201314% of the compounds displayed pro-infective activity. Our studies underline the relevance of using evolutionarily distant pathogen and host models in order to reveal conserved mechanisms of virulence and defence, respectively, which are potential \u201cuniversal\u201d targets for intervention. Subsequent mechanism of action studies based on generation of over-expresser <jats:italic>M. bovis<\/jats:italic> BCG strains, generation of spontaneous resistant mutants and whole genome sequencing revealed four new molecular targets, including FbpA, MurC, MmpL3 and GlpK.<\/jats:p>","DOI":"10.1038\/s41598-018-22228-6","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T13:33:10Z","timestamp":1519651990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Antimycobacterial drug discovery using Mycobacteria-infected amoebae identifies anti-infectives and new molecular targets"],"prefix":"10.1038","volume":"8","author":[{"given":"Valentin","family":"Trofimov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Kicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Mucaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Ramon-Olayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Vela-Gonzalez","family":"Del Peral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00ebl","family":"Leli\u00e8vre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"Ballell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Scapozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5605-0395","authenticated-orcid":false,"given":"Gurdyal S.","family":"Besra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A. G.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Soldati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,2]]},"reference":[{"key":"22228_CR1","unstructured":"WHO. Global Tuberculosis Report 2013. (World Health Organization, 2013)."},{"key":"22228_CR2","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1128\/AAC.00749-08","volume":"53","author":"J van den Boogaard","year":"2009","unstructured":"van den Boogaard, J., Kibiki, G. S., Kisanga, E. R., Boeree, M. J. & Aarnoutse, R. E. New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development. Antimicrobial agents and chemotherapy 53, 849\u2013862 (2009).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"22228_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","volume":"44","author":"CA Lipinski","year":"2000","unstructured":"Lipinski, C. A. Drug-like properties and the causes of poor solubility and poor permeability. Journal of pharmacological and toxicological methods 44, 235\u2013249 (2000).","journal-title":"Journal of pharmacological and toxicological methods"},{"key":"22228_CR4","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1084\/jem.134.3.713","volume":"134","author":"JA Armstrong","year":"1971","unstructured":"Armstrong, J. A. & Hart, P. D. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. The Journal of experimental medicine 134, 713\u2013740 (1971).","journal-title":"The Journal of experimental medicine"},{"key":"22228_CR5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/35085034","volume":"2","author":"DG Russell","year":"2001","unstructured":"Russell, D. G. Mycobacterium tuberculosis: here today, and here tomorrow. Nature reviews Molecular cell biology 2, 569\u2013577 (2001).","journal-title":"Nature reviews Molecular cell biology"},{"key":"22228_CR6","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.cell.2010.02.012","volume":"140","author":"D Kumar","year":"2010","unstructured":"Kumar, D. et al. Genome-wide analysis of the host intracellular network that regulates survival of Mycobacterium tuberculosis. Cell 140, 731\u2013743 (2010).","journal-title":"Cell"},{"key":"22228_CR7","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cell.2004.11.038","volume":"119","author":"MG Gutierrez","year":"2004","unstructured":"Gutierrez, M. G. et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119, 753\u2013766 (2004).","journal-title":"Cell"},{"key":"22228_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrmicro840","volume":"2","author":"A Koul","year":"2004","unstructured":"Koul, A., Herget, T., Klebl, B. & Ullrich, A. Interplay between mycobacteria and host signalling pathways. Nature reviews Microbiology 2, 189\u2013202 (2004).","journal-title":"Nature reviews Microbiology"},{"key":"22228_CR9","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.4049\/jimmunol.164.4.2016","volume":"164","author":"J Keane","year":"2000","unstructured":"Keane, J., Remold, H. G. & Kornfeld, H. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. Journal of immunology 164, 2016\u20132020 (2000).","journal-title":"Journal of immunology"},{"key":"22228_CR10","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nrmicro2387","volume":"8","author":"SM Behar","year":"2010","unstructured":"Behar, S. M., Divangahi, M. & Remold, H. G. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? Nature reviews Microbiology 8, 668\u2013674 (2010).","journal-title":"Nature reviews Microbiology"},{"key":"22228_CR11","doi-asserted-by":"publisher","first-page":"e367","DOI":"10.1371\/journal.pbio.0020367","volume":"2","author":"HE Volkman","year":"2004","unstructured":"Volkman, H. E. et al. Tuberculous granuloma formation is enhanced by a mycobacterium virulence determinant. PLoS biology 2, e367 (2004).","journal-title":"PLoS biology"},{"key":"22228_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2008.11.014","volume":"136","author":"JM Davis","year":"2009","unstructured":"Davis, J. M. & Ramakrishnan, L. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136, 37\u201349 (2009).","journal-title":"Cell"},{"key":"22228_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd2201","volume":"6","author":"DJ Payne","year":"2007","unstructured":"Payne, D. J., Gwynn, M. N., Holmes, D. J. & Pompliano, D. L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nature reviews Drug discovery 6, 29\u201340 (2007).","journal-title":"Nature reviews Drug discovery"},{"key":"22228_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nrmicro1818","volume":"6","author":"L Cegelski","year":"2008","unstructured":"Cegelski, L., Marshall, G. R., Eldridge, G. R. & Hultgren, S. J. The biology and future prospects of antivirulence therapies. Nature reviews Microbiology 6, 17\u201327 (2008).","journal-title":"Nature reviews Microbiology"},{"key":"22228_CR15","doi-asserted-by":"publisher","first-page":"e1000645","DOI":"10.1371\/journal.ppat.1000645","volume":"5","author":"T Christophe","year":"2009","unstructured":"Christophe, T. et al. High content screening identifies decaprenyl-phosphoribose 2\u2019 epimerase as a target for intracellular antimycobacterial inhibitors. PLoS pathogens 5, e1000645 (2009).","journal-title":"PLoS pathogens"},{"key":"22228_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.tube.2006.12.001","volume":"87","author":"RC Hartkoorn","year":"2007","unstructured":"Hartkoorn, R. C. et al. Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein. Tuberculosis 87, 248\u2013255 (2007).","journal-title":"Tuberculosis"},{"key":"22228_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-4-160","volume":"4","author":"X Fang","year":"2010","unstructured":"Fang, X., Wallqvist, A. & Reifman, J. Development and analysis of an in vivo-compatible metabolic network of Mycobacterium tuberculosis. BMC systems biology 4, 160 (2010).","journal-title":"BMC systems biology"},{"key":"22228_CR18","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1164\/rccm.200904-0536OC","volume":"180","author":"JL Johnson","year":"2009","unstructured":"Johnson, J. L. et al. Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion. American journal of respiratory and critical care medicine 180, 558\u2013563 (2009).","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"Suppl 1","key":"22228_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1590\/S0074-02762012000900023","volume":"107","author":"KA de Mattos","year":"2012","unstructured":"de Mattos, K. A., Sarno, E. N., Pessolani, M. C. & Bozza, P. T. Deciphering the contribution of lipid droplets in leprosy: multifunctional organelles with roles in Mycobacterium leprae pathogenesis. Memorias do Instituto Oswaldo Cruz 107(Suppl 1), 156\u2013166 (2012).","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"key":"22228_CR20","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1128\/IAI.01196-13","volume":"82","author":"I Caire-Brandli","year":"2014","unstructured":"Caire-Brandli, I. et al. Reversible lipid accumulation and associated division arrest of Mycobacterium avium in lipoprotein-induced foamy macrophages may resemble key events during latency and reactivation of tuberculosis. Infection and immunity 82, 476\u2013490 (2014).","journal-title":"Infection and immunity"},{"key":"22228_CR21","doi-asserted-by":"publisher","first-page":"e1002093","DOI":"10.1371\/journal.ppat.1002093","volume":"7","author":"J Daniel","year":"2011","unstructured":"Daniel, J., Maamar, H., Deb, C., Sirakova, T. D. & Kolattukudy, P. E. Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages. PLoS pathogens 7, e1002093 (2011).","journal-title":"PLoS pathogens"},{"key":"22228_CR22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nrmicro2836","volume":"10","author":"MI Hood","year":"2012","unstructured":"Hood, M. I. & Skaar, E. P. Nutritional immunity: transition metals at the pathogen-host interface. Nature reviews Microbiology 10, 525\u2013537 (2012).","journal-title":"Nature reviews Microbiology"},{"key":"22228_CR23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/emmm.201201772","volume":"6","author":"B Lechartier","year":"2014","unstructured":"Lechartier, B., Rybniker, J., Zumla, A. & Cole, S. T. Tuberculosis drug discovery in the post-post-genomic era. EMBO molecular medicine 6, 158\u2013168 (2014).","journal-title":"EMBO molecular medicine"},{"key":"22228_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.mib.2009.11.006","volume":"13","author":"MU Shiloh","year":"2010","unstructured":"Shiloh, M. U. & Champion, P. A. To catch a killer. What can mycobacterial models teach us about Mycobacterium tuberculosis pathogenesis? Current opinion in microbiology 13, 86\u201392 (2010).","journal-title":"Current opinion in microbiology"},{"key":"22228_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1600-0684.2012.00536.x","volume":"41","author":"D Kaushal","year":"2012","unstructured":"Kaushal, D., Mehra, S., Didier, P. J. & Lackner, A. A. The non-human primate model of tuberculosis. Journal of medical primatology 41, 191\u2013201 (2012).","journal-title":"Journal of medical primatology"},{"key":"22228_CR26","doi-asserted-by":"publisher","first-page":"a018572","DOI":"10.1101\/cshperspect.a018572","volume":"5","author":"S Clark","year":"2014","unstructured":"Clark, S., Hall, Y. & Williams, A. Animal models of tuberculosis: Guinea pigs. Cold Spring Harbor perspectives in medicine 5, a018572 (2014).","journal-title":"Cold Spring Harbor perspectives in medicine"},{"key":"22228_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2174\/157489108784746579","volume":"3","author":"BV Nikonenko","year":"2008","unstructured":"Nikonenko, B. V., Sacksteder, K. A., Hundert, S., Einck, L. & Nacy, C. A. Preclinical study of new TB drugs and drug combinations in mouse models. Recent patents on anti-infective drug discovery 3, 102\u2013116 (2008).","journal-title":"Recent patents on anti-infective drug discovery"},{"key":"22228_CR28","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1242\/dmm.016089","volume":"7","author":"MR Cronan","year":"2014","unstructured":"Cronan, M. R. & Tobin, D. M. Fit for consumption: zebrafish as a model for tuberculosis. Disease models & mechanisms 7, 777\u2013784 (2014).","journal-title":"Disease models & mechanisms"},{"key":"22228_CR29","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/jac\/dks425","volume":"68","author":"CT Oh","year":"2013","unstructured":"Oh, C. T., Moon, C., Choi, T. H., Kim, B. S. & Jang, J. Mycobacterium marinum infection in Drosophila melanogaster for antimycobacterial activity assessment. The Journal of antimicrobial chemotherapy 68, 601\u2013609 (2013).","journal-title":"The Journal of antimicrobial chemotherapy"},{"key":"22228_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.micpath.2014.07.009","volume":"77","author":"N Tosetti","year":"2014","unstructured":"Tosetti, N., Croxatto, A. & Greub, G. Amoebae as a tool to isolate new bacterial species, to discover new virulence factors and to study the host-pathogen interactions. Microbial pathogenesis 77, 125\u2013130 (2014).","journal-title":"Microbial pathogenesis"},{"key":"22228_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.semcdb.2010.11.003","volume":"22","author":"M Steinert","year":"2011","unstructured":"Steinert, M. Pathogen-host interactions in Dictyostelium, Legionella, Mycobacterium and other pathogens. Seminars in cell & developmental biology 22, 70\u201376 (2011).","journal-title":"Seminars in cell & developmental biology"},{"key":"22228_CR32","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.coi.2004.05.011","volume":"16","author":"TC Pozos","year":"2004","unstructured":"Pozos, T. C. & Ramakrishnan, L. New models for the study of Mycobacterium-host interactions. Current opinion in immunology 16, 499\u2013505 (2004).","journal-title":"Current opinion in immunology"},{"key":"22228_CR33","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.ejcb.2006.05.010","volume":"85","author":"A Balbo","year":"2006","unstructured":"Balbo, A. & Bozzaro, S. Cloning of Dictyostelium eIF6 (p27BBP) and mapping its nucle(ol)ar localization subdomains. Eur J Cell Biol 85, 1069\u20131078 (2006).","journal-title":"Eur J Cell Biol"},{"key":"22228_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.semcdb.2010.11.006","volume":"22","author":"WC Lima","year":"2011","unstructured":"Lima, W. C., Lelong, E. & Cosson, P. What can Dictyostelium bring to the study of Pseudomonas infections? Seminars in cell & developmental biology 22, 77\u201381 (2011).","journal-title":"Seminars in cell & developmental biology"},{"key":"22228_CR35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1462-5822.2009.01413.x","volume":"12","author":"M Clarke","year":"2010","unstructured":"Clarke, M. Recent insights into host-pathogen interactions from Dictyostelium. Cellular microbiology 12, 283\u2013291 (2010).","journal-title":"Cellular microbiology"},{"key":"22228_CR36","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1126\/science.1169381","volume":"323","author":"M Hagedorn","year":"2009","unstructured":"Hagedorn, M., Rohde, K. H., Russell, D. G. & Soldati, T. Infection by tubercular mycobacteria is spread by nonlytic ejection from their amoeba hosts. Science 323, 1729\u20131733 (2009).","journal-title":"Science"},{"key":"22228_CR37","doi-asserted-by":"publisher","first-page":"e87834","DOI":"10.1371\/journal.pone.0087834","volume":"9","author":"S Kicka","year":"2014","unstructured":"Kicka, S. et al. Establishment and validation of whole-cell based fluorescence assays to identify anti-mycobacterial compounds using the Acanthamoeba castellanii-Mycobacterium marinum host-pathogen system. PloS one 9, e87834 (2014).","journal-title":"PloS one"},{"key":"22228_CR38","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1021\/acsinfecdis.5b00002","volume":"1","author":"CF Harrison","year":"2015","unstructured":"Harrison, C. F. et al. Amoebae-Based Screening Reveals a Novel Family of Compounds Restricting Intracellular Legionella pneumophila. ACS infectious diseases 1, 327\u2013338 (2015).","journal-title":"ACS infectious diseases"},{"key":"22228_CR39","doi-asserted-by":"publisher","first-page":"e74813","DOI":"10.1371\/journal.pone.0074813","volume":"8","author":"CF Harrison","year":"2013","unstructured":"Harrison, C. F. et al. Exploring anti-bacterial compounds against intracellular Legionella. PloS one 8, e74813 (2013).","journal-title":"PloS one"},{"key":"22228_CR40","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/cmdc.201200428","volume":"8","author":"L Ballell","year":"2013","unstructured":"Ballell, L. et al. Fueling open-source drug discovery: 177 small-molecule leads against tuberculosis. ChemMedChem 8, 313\u2013321 (2013).","journal-title":"ChemMedChem"},{"key":"22228_CR41","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1021\/ml200036r","volume":"2","author":"GC Moraski","year":"2011","unstructured":"Moraski, G. C. et al. Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity. ACS medicinal chemistry letters 2, 466\u2013470 (2011).","journal-title":"ACS medicinal chemistry letters"},{"key":"22228_CR42","doi-asserted-by":"publisher","first-page":"e0121492","DOI":"10.1371\/journal.pone.0121492","volume":"10","author":"G Mugumbate","year":"2015","unstructured":"Mugumbate, G. et al. Mycobacterial dihydrofolate reductase inhibitors identified using chemogenomic methods and in vitro validation. PloS one 10, e0121492 (2015).","journal-title":"PloS one"},{"key":"22228_CR43","doi-asserted-by":"publisher","first-page":"e52951","DOI":"10.1371\/journal.pone.0052951","volume":"7","author":"KA Abrahams","year":"2012","unstructured":"Abrahams, K. A. et al. Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB. PloS one 7, e52951 (2012).","journal-title":"PloS one"},{"key":"22228_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12581","volume":"7","author":"KA Abrahams","year":"2016","unstructured":"Abrahams, K. A. et al. Identification of KasA as the cellular target of an anti-tubercular scaffold. Nature communications 7, 12581 (2016).","journal-title":"Nature communications"},{"key":"22228_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/srep38986","volume":"6","author":"JA Cox","year":"2016","unstructured":"Cox, J. A. et al. Novel inhibitors of Mycobacterium tuberculosis GuaB2 identified by a target based high-throughput phenotypic screen. Scientific reports 6, 38986 (2016).","journal-title":"Scientific reports"},{"key":"22228_CR46","doi-asserted-by":"publisher","first-page":"e1002251","DOI":"10.1371\/journal.ppat.1002251","volume":"7","author":"JE Griffin","year":"2011","unstructured":"Griffin, J. E. et al. High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism. PLoS pathogens 7, e1002251 (2011).","journal-title":"PLoS pathogens"},{"key":"22228_CR47","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1111\/j.1462-5822.2007.00993.x","volume":"9","author":"M Hagedorn","year":"2007","unstructured":"Hagedorn, M. & Soldati, T. Flotillin and RacH modulate the intracellular immunity of Dictyostelium to Mycobacterium marinum infection. Cell Microbiol 9, 2716\u20132733 (2007).","journal-title":"Cell Microbiol"},{"key":"22228_CR48","doi-asserted-by":"publisher","first-page":"e1000895","DOI":"10.1371\/journal.ppat.1000895","volume":"6","author":"F Carlsson","year":"2010","unstructured":"Carlsson, F. et al. Host-detrimental role of Esx-1-mediated inflammasome activation in mycobacterial infection. PLoS pathogens 6, e1000895 (2010).","journal-title":"PLoS pathogens"},{"key":"22228_CR49","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1128\/EC.1.4.643-652.2002","volume":"1","author":"C Anjard","year":"2002","unstructured":"Anjard, C., Loomis, W. F. & Dictyostelium Sequencing, C. Evolutionary analyses of ABC transporters of Dictyostelium discoideum. Eukaryotic cell 1, 643\u2013652 (2002).","journal-title":"Eukaryotic cell"},{"key":"22228_CR50","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1128\/IAI.68.2.767-778.2000","volume":"68","author":"LY Armitige","year":"2000","unstructured":"Armitige, L. Y., Jagannath, C., Wanger, A. R. & Norris, S. J. Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages. Infection and immunity 68, 767\u2013778 (2000).","journal-title":"Infection and immunity"},{"key":"22228_CR51","doi-asserted-by":"publisher","first-page":"6827","DOI":"10.1128\/JB.182.23.6827-6830.2000","volume":"182","author":"S Mahapatra","year":"2000","unstructured":"Mahapatra, S., Crick, D. C. & Brennan, P. J. Comparison of the UDP-N-acetylmuramate:L-alanine ligase enzymes from Mycobacterium tuberculosis and Mycobacterium leprae. Journal of bacteriology 182, 6827\u20136830 (2000).","journal-title":"Journal of bacteriology"},{"key":"22228_CR52","doi-asserted-by":"publisher","first-page":"e60143","DOI":"10.1371\/journal.pone.0060143","volume":"8","author":"T Munshi","year":"2013","unstructured":"Munshi, T. et al. Characterisation of ATP-dependent Mur ligases involved in the biogenesis of cell wall peptidoglycan in Mycobacterium tuberculosis. PloS one 8, e60143 (2013).","journal-title":"PloS one"},{"key":"22228_CR53","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1128\/AAC.00826-16","volume":"60","author":"W Li","year":"2016","unstructured":"Li, W. et al. Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3. Antimicrobial agents and chemotherapy 60, 5198\u20135207 (2016).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"22228_CR54","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nchembio.794","volume":"8","author":"AE Grzegorzewicz","year":"2012","unstructured":"Grzegorzewicz, A. E. et al. Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane. Nature chemical biology 8, 334\u2013341 (2012).","journal-title":"Nature chemical biology"},{"key":"22228_CR55","doi-asserted-by":"publisher","first-page":"6232","DOI":"10.1021\/acs.jmedchem.6b00415","volume":"59","author":"J Stec","year":"2016","unstructured":"Stec, J. et al. Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection. Journal of medicinal chemistry 59, 6232\u20136247 (2016).","journal-title":"Journal of medicinal chemistry"},{"key":"22228_CR56","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2217\/fmb.12.56","volume":"7","author":"KA Sacksteder","year":"2012","unstructured":"Sacksteder, K. A., Protopopova, M., Barry, C. E. 3rd, Andries, K. & Nacy, C. A. Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action. Future microbiology 7, 823\u2013837 (2012).","journal-title":"Future microbiology"},{"key":"22228_CR57","doi-asserted-by":"publisher","first-page":"214ra168","DOI":"10.1126\/scitranslmed.3007355","volume":"5","author":"SP Rao","year":"2013","unstructured":"Rao, S. P. et al. Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis. Science translational medicine 5, 214ra168 (2013).","journal-title":"Science translational medicine"},{"key":"22228_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3907","volume":"4","author":"S Lun","year":"2013","unstructured":"Lun, S. et al. Indoleamides are active against drug-resistant Mycobacterium tuberculosis. Nature communications 4, 2907 (2013).","journal-title":"Nature communications"},{"key":"22228_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1060","volume":"1","author":"K Pethe","year":"2010","unstructured":"Pethe, K. et al. A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy. Nat Commun 1, 57 (2010).","journal-title":"Nat Commun"},{"key":"22228_CR60","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1128\/AAC.01920-15","volume":"60","author":"F Sorrentino","year":"2015","unstructured":"Sorrentino, F. et al. Development of an Intracellular Screen for New Compounds Able To Inhibit Mycobacterium tuberculosis Growth in Human Macrophages. Antimicrobial agents and chemotherapy 60, 640\u2013645 (2015).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"22228_CR61","doi-asserted-by":"publisher","first-page":"e10777","DOI":"10.1371\/journal.pone.0010777","volume":"5","author":"N Andreu","year":"2010","unstructured":"Andreu, N. et al. Optimisation of bioluminescent reporters for use with mycobacteria. PLoS One 5, e10777 (2010).","journal-title":"PLoS One"},{"key":"22228_CR62","doi-asserted-by":"publisher","first-page":"e9823","DOI":"10.1371\/journal.pone.0009823","volume":"5","author":"P Carroll","year":"2010","unstructured":"Carroll, P. et al. Sensitive detection of gene expression in mycobacteria under replicating and non-replicating conditions using optimized far-red reporters. PLoS One 5, e9823 (2010).","journal-title":"PLoS One"},{"key":"22228_CR63","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1111\/j.1462-5822.2007.01005.x","volume":"9","author":"A Tiaden","year":"2007","unstructured":"Tiaden, A. et al. The Legionella pneumophila response regulator LqsR promotes host cell interactions as an element of the virulence regulatory network controlled by RpoS and LetA. Cell Microbiol 9, 2903\u20132920 (2007).","journal-title":"Cell Microbiol"},{"key":"22228_CR64","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1111\/j.1471-4159.2005.03014.x","volume":"92","author":"S Lund","year":"2005","unstructured":"Lund, S. et al. Inhibition of microglial inflammation by the MLK inhibitor CEP-1347. J Neurochem 92, 1439\u20131451 (2005).","journal-title":"J Neurochem"},{"key":"22228_CR65","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1093\/jac\/dkt155","volume":"68","author":"N Andreu","year":"2013","unstructured":"Andreu, N. et al. Rapid in vivo assessment of drug efficacy against Mycobacterium tuberculosis using an improved firefly luciferase. The Journal of antimicrobial chemotherapy 68, 2118\u20132127 (2013).","journal-title":"The Journal of antimicrobial chemotherapy"},{"key":"22228_CR66","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/978-1-62703-302-2_22","volume":"983","author":"S Arafah","year":"2013","unstructured":"Arafah, S. et al. Setting up and monitoring an infection of Dictyostelium discoideum with mycobacteria. Methods in molecular biology 983, 403\u2013417 (2013).","journal-title":"Methods in molecular biology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22228-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22228-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22228-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T03:05:10Z","timestamp":1671591910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22228-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,2]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["22228"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-22228-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,2]]},"assertion":[{"value":"30 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.R.O., L.V.G.D.P., L.B., J.L. and J.A.G.C. are or have been employees of G.S.K.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3939"}}